CEL-SCI CORPORATION Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements
CEL-SCI CORPORATION (CVM) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements of -$3.59 million for the 12-month period ending 2019-09-30, per its 10-K/A filed 2019-12-23.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements · last filed 2019-12-23
- CEL-SCI CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2014-12-31 was $0.00.
- CEL-SCI CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2019 was -$3.59M.
- CEL-SCI CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2018 was -$595.78K.
- CEL-SCI CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2017 was $0.00.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 12 month |
|---|---|---|---|
| 2019-09-30 | -$3.59M 10-K/A · filed 2019-12-23 | ||
| 2018-09-30 | -$595.78K 10-K/A · filed 2019-12-23 | ||
| 2017-09-30 | $0.00 10-K · filed 2018-12-19 | ||
| 2015-06-30 | $0.00 10-Q · filed 2015-08-07 | ||
| 2014-12-31 | $0.00 10-Q · filed 2015-02-06 | ||
| 2014-09-30 | -$1.45M 10-Q · filed 2015-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |